Aurio Limited

Product: 
Life Sciences
Status: 
Closed
Sector: 
Tinnitus Technology
Aim of funding: 
Seed
HMRC Advance Assurance received: 
Yes

Aurio Limited

Description: 

Aurio Limited has developed a patentable core technology that potentially eases the debilitating effects of tinnitus. 

Tinnitus is a perception of sound in the absence of an external source. Although it is often referred to as ‘ringing in the ears’, tinnitus can also be perceived as many different sounds including hissing, clicking or whistling. A common condition, it affects approximately 1 in every 10 adults, especially those over the age of 60. Common causes are excessive or cumulative noise exposure, head and neck injuries, and ear infections. In a small number of individuals, tinnitus is a sign of a serious underlying medical condition.  The adverse impacts of tinnitus include insomnia, poor concentration and performance, irritability, anxiety and depression.

There is currently no cure for tinnitus. The development of ‘Aurio Soundscapes’ enables sufferers to more effectively manage their condition and thereby improve their quality of life. The Aurio technology currently runs on iOS mobile devices, and the underlying algorithms that manage the individual’s unique sets of ‘brown’, ‘pink’ and ‘white’ noise are fully controllable and customisable by the user.

Opportunity: 

In 2008, the American Tinnitus Association (ATA) estimated that over 50 million Americans experienced some degree of tinnitus. Of these, 12 million had tinnitus of a severe nature that led to the sufferer seeking medical attention and roughly 2 million persons are so debilitated by tinnitus they could not function at a normal level on a day-to-day basis. According to Aurio, the immediate reachable market for Aurio Soundscapes is estimated at 49 million across the USA, UK and Canada. Of these, Aurio estmates that 17 million suffer from continuous, constant tinnitus. It is estimated that China, as one further example, has 130 million Tinnitus sufferers according to medical estimates published in 2005 by Chinese News Agency Xinhua..

Information on this webpage relates to and is provided by Deepbridge Advisers Limited.

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Deepbridge Capital LLP, Deepbridge Advisers Limited and Enterprise Partners LLP (together "the Sponsors," or "Sponsor) do not provide specific individual advice on the suitability of investments with regard to a potential investor's individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.